Home » Newsletters » BioWorld Science

BioWorld Science

April 18, 1997

View Archived Issues

Update on Neurogen's schizophrenia program

Sugen and Hoechst Marion Roussel enter cancer drug research agreement

Cytel reports potent immunostimulant useful in vaccine development

Aricept launched in U.K.

U.K. launch for Campto

Naropin introduced in Germany

Novartis prepares novel signal transduction inhibitors

Factor Xa inhibitors from Boehringer Mannheim

BASF describes new glutamate antagonists

Inhibitors of ICE and ICE-like proteins claimed by SmithKline Beecham

KREATECH and Saliva Diagnostic Systems receive grant for TB test

Morinaga Milk claims new antiparasitic agents

Positive phase I data reported for liposomal PGE1 product for erectile dysfunction

Natural antifungal/antitumor agents discovered by Fujisawa

Estrogen receptor structure elucidated

Cholecystokinin antagonists for pancreatic disorders described by Tanabe

Anti-CD44 antisense oligonucleotides prepared by ICN

MEDI-507 heads for clinical trials

LeukoScan introduced yesterday in Germany

Quantison enters phase II trials

New MMP inhibitor disclosed by Agouron

Warner-Lambert describes new dopamine D4 antagonists

Synergistic benefit of citicoline and NMDA antagonist shown in animal models of stroke

NitroMed and Cordis collaborate to develop novel cardiovascular products

Ergo Science and Massachusetts General Hospital conclude licensing agreement

Royce Laboratories' generic antiinflammatory approved by FDA

PDT expands phase II/III trial of Purlytin

Watson and Royce Laboratories merge

ImmuCell to initiate clinical trial of DiffGAM

Atorvastatin available in Germany for hyperlipidemia

Alteon reports positive results from phase II trials with pimagedine

Zagam available in Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...